Form 4: Unity Biotechnology CEO Anirvan Ghosh Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Anirvan Ghosh sold shares of Unity Biotechnology to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On April 2, 2025, Anirvan Ghosh, CEO of Unity Biotechnology, sold 96,797 shares of common stock at a price of $1.03 per share.
- The sale was executed under a Rule 10b5-1 trading plan to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Ghosh directly owns 153,454 shares, which includes RSUs that vest over time from the grant date.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a common practice among executives who receive equity compensation. The use of a 10b5-1 plan indicates that the sales were pre-planned and not based on insider information.
Stakeholder Impact
- The sale of shares by the CEO could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 04/02/2025 | Date of the transaction: Anirvan Ghosh sold shares of Unity Biotechnology. |
| 04/03/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Unity Biotechnology, Anirvan Ghosh, UBX, share sale, Rule 10b5-1, Restricted Stock Units, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.